Gabapentin–saccharin co-crystals with enhanced physicochemical properties and in vivo absorption formulated as oro-dispersible tablets

References

• Abolghasem J. 2009. Handbook of solubility data for pharmaceutical. London: CRC Press.
   Google Scholar
• Aitipamula S, Wong ABH, Kanaujia P. Evaluating suspension formulations of theophylline cocrystals with artificial sweeteners. J Pharm Sci. 2018;107(2):604–611.
   PubMed Web of Science ®Google Scholar
• Akkurt HE, Gümüs H, Göksu H, Ömer FO, Halim Y. Gabapentin treatment for neuropathic pain in a child with sciatic nerve injury. Case Rep Med. 2015:873157.
   PubMed Web of Science ®Google Scholar
• Alhalaweh A, Roy L, Rodríguez-Hornedo N, Velaga SP. 2012. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media. Mol Pharm. 9(9):2605–2612.
   PubMedGoogle Scholar
• Amani S, Abedinzadeh MR. 2015. Effects of oral gabapentin, local bupivacaine and intravenous pethidine on post tonsillectomy pain. Iran J Otorhinolaryngol. 27(82):343–348.
   PubMedGoogle Scholar
• Ananda K, Aravinda S, Vasudev PG, Raja KMP, Sivaramakrishnan H, Nagarajan K, et al. 2003. Stereochemistry of gabapentin and several derivatives: solid state conformations and solution equilibria. Curr Sci. 85:1002.
   Web of Science ®Google Scholar
• Badgujar BP, Mundada AS. 2011. The technologies used for developing orally disintegrating tablets: a review. Acta Pharm. 61(2):117–139.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Bhatt PM, Ravindra NV, Desiraju GR. 2005. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities. Cryst Growth Des. 5(6):2299–2309.
   Web of Science ®Google Scholar
• Basavoju S, Boström D, Velaga SP. 2008. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res. 25(3):530–541.
   PubMed Web of Science ®Google Scholar
• Cao F, Amidon GL, Naír Rodríguez-Hornedo N, Amidon GE. 2018. Mechanistic basis of cocrystal dissolution advantage. J Pharm Sci. 107(1):380–389.
   PubMed Web of Science ®Google Scholar
• Carolina BR, Ruben HM, Yamila GL, Ana KC, Gustavo AM, Maria EO. 2009. Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones. J Pharm Sci. 98(10):3788–3801.
   PubMed Web of Science ®Google Scholar
• Cundy KC, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, et al. 2004. XP13512 [(+/-)-1-([(alphaisobutanoyloxyethoxy) carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther. 311(1):324–333.
   PubMed Web of Science ®Google Scholar
• Dai XL, Li S, Chen JM, Lu TB. 2016. Improving the membrane permeability of 5-fluorouracil via cocrystallization. Cryst Growth Des. 16(8):4430–4438.
   Web of Science ®Google Scholar
• Dasharath MP, Hardik RS, Rahul JP, Chhagan NP. 2014. Preparation and characterization of lornoxicam co-crystals. World J Pharm Pharm Sci. 3(6):713–732.
   Google Scholar
• Dembla NM, Maniyam AP, Agarwal S. 2015. Formulation development and evaluation of gabapentin controlled release tablets. Pharm Pharmacol Int J. 2(3):00021.
   Google Scholar
• Duggirala NK, Smith AJ, Wojtas L, Shytle RD, Zaworotko MJ. 2014. Physical stability enhancement and pharmacokinetics of a lithium ionic cocrystal with glucose. Cryst Growth Des. 14(11):6135–6142.
   Web of Science ®Google Scholar
• Ebtsam MA. 2018. Sweet co-crystals for pediatric drugs formulation. Acta Sci Pharm Sci Editorial. 87(4):28.
   Google Scholar
• Edwards L, DeMeo S, Hornik CD, Cotten CM, Smith PB, Pizoli C, Hauer JM, Bidegain M. 2016. Gabapentin use in the neonatal intensive care unit. J Pediatr. 169:310–312.
   PubMed Web of Science ®Google Scholar
• FDA Guidance. Guidance for Industry: Regulatory classification of pharmaceutical cocrystals. [accessed 2013 Sep]. http://www.fda.gov/media/99917/download.
   Google Scholar
• Gujral RS, Haque SM. 2009. Development and validation of a new hplc method for the determination of gabapentin. Int J Biomed Sci. 5(1):63–69.
   PubMedGoogle Scholar
• Haig GM, Bockbrader HN, Wesche DL, Boellner SW, Ouellet D, Brown RR, Randinitis EJ, Posvar EL. 2001. Single-dose gabapentin pharmacokinetics and safety in healthy infants and children. J Clin Pharmacol. 41(5):507–514.
   PubMed Web of Science ®Google Scholar
• Honarmand A, Safavi M, Zare M. 2011. Gabapentin: an update of its pharmacological properties and therapeutic use in epilepsy. J Res Med Sci. 16(8):1062–1069.
   PubMed Web of Science ®Google Scholar
• Hsu CH, Ke W, Lin S. 2010. Progressive steps of polymorphic transformation of gabapentin polymorphs studied by hot-stage FTIR microspectroscopy. J Pharm Pharm Sci. 13(1):67–77.
   PubMed Web of Science ®Google Scholar
• Ibrahim AY, Forbes RT, Blagden N. 2011. Spontaneous crystal growth of co-crystals: the contribution of particle size reduction and convection mixing of the co-formers. Cryst Eng Commun. 13(4):1141–1152.
   Google Scholar
• Iman IS, Ebtesam MA, Nagua HF. 2013. Formulation and evaluation of teste-masked ciprofloxacin bioadhesive dental films. Asian J Pharm. 9:133–139.
   Google Scholar
• Iman IS, Elham AA, Gaddah A. 2014. Evaluation of extemporaneous pediatric gabapentin suspension prepared from gabapentin capsules. Lat Amer J Pharma. 33(5):746–752.
   Web of Science ®Google Scholar
• Iyan S, Achmad F, Muchtaridi M, IkaPuspita S. 2017. Co-crystallization: a tool to enhance solubility and dissolution rate of simvastatin. JYP. 9(2):183–186.
   Web of Science ®Google Scholar
• Jonathan JD, Linda V, Peter AW, Paul WG, Jacob O, James AP, Hibbs DE. 2016. An analysis of the experimental and theoreticalcharge density distributions of the piroxicam–saccharin co-crystal and its constituents. RSC Adv. 6:81578–81590.
   Web of Science ®Google Scholar
• Jujjuru NSK, Raghavendra KG. 2018. Design, formulation and evaluation of pravastatin fast dissolving tablets. Pharm Methods. 9(1):16–23.
   Google Scholar
• Kafa KH, Ryadh RN, Issam SH, Essa AS. 2014. Qualitative and quantitative determination of artificial sweetener saccharin sodium by FTIR spectroscopy. Int J Adv Pharm Biol Chem. 3(3):617–625.
   Google Scholar
• Kalyankar P, Panzade P, Lahoti S. 2015. Formulation design and optimization of orodispersible tablets of quetiapine fumarate by sublimation method. Indian J Pharm Sci. 77(3):267–273.
   PubMed Web of Science ®Google Scholar
• Kapil D, Vandana K, Anupama S, Vikas AS, Hemant J, Suresh P. 2014. A proposed methodology for in vitro evaluation of bitterness in drug solutions and in vitro drug release samples. J Pharm Innov. 9:183–191.
   Web of Science ®Google Scholar
• Karimi-Jafari M, Padrela L, Walker GM, Croker DM. 2018. Creating cocrystals: a review of pharmaceutical cocrystal preparation routes and applications. Cryst Growth Des. 18(10):6370–6387.
   Web of Science ®Google Scholar
• Kearney AS, Mehta SC, Radebaugh GW. 1992. The effect of cyclodextrins on the rate of intramolecular lactamization of gabapentin in aqueous solution. Int J Pharm. 78(1–3):25.
   Google Scholar
• Kumar MU, Babu MK. 2014. Design and evaluation of fast dissolving tablets containing diclofenac sodium using fenugreek gum as a natural superdisintegrant. Asian Pac J Trop Biomed. 4(1):S329–S334.
   PubMedGoogle Scholar
• Matos MAR, Miranda MS, Morais VMF, Liebman JF. 2005. Saccharin: a combined experimental and computational thermochemical investigation of a sweetener and sulfonamide. Mol Phys. 103:221–228.
   Web of Science ®Google Scholar
• Mayell A, Srinivasan I, Campbell F, Peliowski A. 2014. Analgesic effects of gabapentin after scoliosis surgery in children: a randomized controlled trial. Paediatr Anaesth. 24(12):1239–1244.
   PubMed Web of Science ®Google Scholar
• Mohanachandran PS, Sindhumol PG, Kiran TS. 2011. Superdisintegrants: an overview. Int J Pharm Sci Rev Res. 6(1):105–109.
   Google Scholar
• Muhammad I, Sumeira R, Quratulain B, Muhammad IQ, Farhat J, Ahmed K. 2016. Orally disintegrating films: a modern expansion in drug delivery system. Saudi Pharm J. 24(5):537–546.
   PubMed Web of Science ®Google Scholar
• Parind MD, Celine VL, Paul WS. 2016. Review of disintegrants and the disintegration phenomena. J Pharm Sci. 105:2545–e2555.
   PubMed Web of Science ®Google Scholar
• Pinki R, Atul KS, Gautam SS, Raj KP, Singh V, Nair SK. 2016. Formulation and evaluation of clarithromycin cocrystals tablets dosage forms to enhance the bioavailability. Pharma Inn Int J. 5(6):05–13.
   Google Scholar
• Qiao N, Li M, Schlindwein W, Malek N, Davies A, Trappitt G. 2011. Pharmaceutical cocrystals: an overview. Int J Pharm. 419(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Ranjous Y, Hsian J. 2013. Improvement in the physical and chemical stability of gabapentin by using different excipients. Int J Pharm Sci Rev Res. 23(1):81–86.
   Google Scholar
• Reddy LS, Bethune SJ, Kampf JW, Rodriguez-Hornedo N. 2009. Co-crystals and salts of gabapentin: ph dependent co-crystal stability and solubility. Cryst Growth Des. 9:378.
   Web of Science ®Google Scholar
• Sanphui P, Devi VK, Clara D, Malviya N, Ganguly S, Desiraju GR. 2015. Cocrystals of hydrochlorothiazide: solubility and diffusion/permeability enhancements through drug–coformer interactions. Mol Pharm. 12(5):1615–1622.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Rohani S. 2015. Cocrystals of Acyclovir with promising physicochemical properties. J Pharm Sci. 104(1):98–105.
   PubMed Web of Science ®Google Scholar
• Shinde AJ, Waghule AN, Paithane A, More HN. 2010. Development and characterisation of oral fast dissolving tablet of nifedipine using camphor as a subliming material. Res J Pharm Biol Chem Sci. 1(1):46–50.
   Google Scholar
• Shinde SM. 2014. Physiochemical evaluation of salt forms of gabapentin and processability into solid unit dosage form. Int J Pharm Biol Sci. 5(4):649–665.
   Google Scholar
• Srinivas B, Dan B, Sitaram PV. 2008. Indomethacin–saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res. 25:3.
   Web of Science ®Google Scholar
• Stewart BH, Kugler AR, Thompson PR, Bockbrader HN. 1993. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res. 10(2):276–282.
   PubMed Web of Science ®Google Scholar
• Suresh B, Venkateshwara RD, Basanth BE. 2017. Development and preliminary characterization of levofloxacin pharmaceutical cocrystals for dissolution rate enhancement. J Pharm Invest. 47(6):583–591.
   Google Scholar
• Svetla D, Maria D, Yancho T, Margarita T. 2016. Determination of particle size distribution and analysis of a natural food supplement on pectin base. IOSR J Pharm. 6(5):1–8.
   Google Scholar
• Tayebi H, Mortazavi SA. 2011. Formulation and evaluation of a novel matrix-type orally disintegrating ibuprofen tablet. Iran J Pharm Res. 10(3):469–479.
   PubMed Web of Science ®Google Scholar
• Taylor CP. 1994. Emerging perspectives on the mechanism of action of gabapentin. Neurology. 44(6 Suppl 5):S10–S16.
   PubMed Web of Science ®Google Scholar
• Tjandrawinata RR, Setiawati E, Putri RS, Yunaidi DA, Amalia F, Susanto LW. 2014. Single dose pharmacokinetic equivalence study of two gabapentin preparations in healthy subjects. Drug Des Dev Ther. 4(8):1249–1255.
   Google Scholar
• Vivek D, Renu BY, Richa A, Sachdev Y. 2017. Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques. Bull Faculty Pharmacy. Cairo Univ. 55:31–39.
   Google Scholar
• Wardell JL, Low JN, Glidewell C. 2005. Saccharin, redetermined at 120 K: a three-dimensional hydrogen-bonded framework. Acta Crystallogr E Struct Rep Online. E61:o1944–o1946.
   Google Scholar
• Yanting H, Bowen Z, Yuan G, Jianjun Z, Limin S. 2014. Baicalein–nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability. J Pharm. 103(8):2330–2337.
   PubMed Web of Science ®Google Scholar